絞り込み

17416

広告

Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease.

著者 Irizarry MC , Yao Y , Hyman BT , Growdon JH , Praticò D
Neurodegener Dis.2007 ; 4(6):403-5.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (32view , 0users)

Full Text Sources

Medical

Miscellaneous

Oxidative damage is implicated in the pathophysiology of Alzheimer's disease (AD). F2-isoprostane is a marker of lipid peroxidation which is elevated in AD CSF. Plasma F2-isoprostane has been proposed as a diagnostic marker for AD and mild cognitive impairment (MCI).
PMID: 17934322 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード